Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice
Journal article published in 2021 by
Marino Clavio,
Elena Crisà 
,
Maurizio Miglino,
Fabio Guolo,
Manuela Ceccarelli,
Flavia Salvi,
Bernardino Allione,
Dario Ferrero,
Enrico Balleari ,
Carlo Finelli,
Antonella Poloni ,
Carmine Selleri,
Paolo Danise,
Daniela Cilloni,
Anna Angela Di Tucci
and other authors.
,
Maurizio Miglino,
Fabio Guolo,
Manuela Ceccarelli,
Flavia Salvi,
Bernardino Allione,
Dario Ferrero,
Enrico Balleari ,
Carlo Finelli,
Antonella Poloni ,
Carmine Selleri,
Paolo Danise,
Daniela Cilloni,
Anna Angela Di Tucci
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 